Unichem Labs stock climbs 6% after turnaround in net profits in Q2

Shares of Unichem Laboratories jumped as much 5.73 per cent at Rs 927.20 per share on the BSE in Wednesday's intraday deals

medicines, durgs, pharma, pharmaceuticals
In 2018-19, 973 brands were pulled out of the market, against 863 in 2017-18
SI Reporter New Delhi
2 min read Last Updated : Nov 13 2024 | 2:43 PM IST
Shares of Unichem Laboratories jumped as much 5.73 per cent at Rs 927.20 per share on the BSE in Wednesday’s intraday deals. This came after the company reported a strong quarterly earnings for the second quarter of financial year 2024-25 (Q2FY25).
 
Unichem Laboratories on Tuesday reported a net profit of Rs 30.49 crore in Q2FY25 versus a net loss of Rs 24.9 crore in the year ago period. 
 
The company’s revenue from operations for the quarter stood at Rs 462 crore in the September quarter of FY25, reflecting an 11.32 per cent decrease from Rs 415 crore in the previous year.  The company’s total expenses dropped by 1.3 per cent to Rs 437 crore, compared with Rs 443 crore in the same quarter last year.
 
Unichem Laboratories’s earnings before interest, tax, depreciation, and amortisation (Ebitda) came in at Rs 58 crore, soaring 566 per cent versus Rs 8.7 crore in the same quarter last year. Ebitda margin improved to 12.55 per cent versus 2.11 per cent in Q2FY24.
 
Unichem Laboratories is an India-based pharmaceutical company that specialises in the manufacture of active pharmaceutical ingredients (APIs). The company operates through four divisions: Unichem Pharma, Unichem Specialities, Unisearch, and Neu-Foreva. 
 
Headquartered in Mumbai, Unichem has five manufacturing facilities located in Roha (Maharashtra), Goa, Ghaziabad (Uttar Pradesh), Pithampur (Madhya Pradesh), and Baddi (Himachal Pradesh).

Unichem Laboratories share price history

The company’s stock has outperformed the market year to date as it has risen 114 per cent, while gaining 115 per cent in the last one year. In comparison BSE Sensex has risen 7.5 per cent year to date and 19.6 per cent in a year. 
 
The company has a total market capitalisation of Rs 6,203.45 crore. Unichem Laboratories shares are trading at a price to earnings multiple of -112.27 times and at an earning per share of Rs -7.81. 
 
At 2:37 PM; the shares of the company were trading 1.10 per cent higher at Rs 886.60 a piece. By comparison, the BSE Sensex was down 1.15 per cent at 77,766.50 level. 
 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Buzzing stocksMarkets Sensex NiftyBSE NSEUnichem Labs

First Published: Nov 13 2024 | 2:42 PM IST

Next Story